Abstract:Prolactin (PRL) is secreted throughout life in men and women. At elevated levels, its physiological role in pregnancy and lactation, and pathological effects, are well known. However clinical implications of low circulating PRL are not well established. We conducted a meta-analysis to examine the relationship between low PRL levels and type 2 diabetes. Five papers included cross-sectional studies comprising 8,720 men (mean age range 51.4–60 years) and 3,429 women (49.5–61.6 years), and four papers included cohort studies comprising 2,948 men (52.1–60.0 years) and 3,203 women (49.2–60.1 years). Individuals with pregnancy, lactation and hyperprolactinemia, drugs known to alter circulating PRL levels, or pituitary diseases had been excluded. Although most studies used quartiles to categorize PRL groups for analysis, PRL cut-off values (all measured by chemiluminescence immunoassay) were variably defined between studies: the lowest PRL quartiles ranged from 3.6 ng/ml to 7.2 ng/ml in men and between 4.5 ng/ml to 8 ng/ml in women; and the highest PRL quartiles ranged from 6.9 ng/ml to 13 ng/ml in men and 9.6 ng/ml to 15.8 ng/ml in women. Type 2 diabetes was defined variably using self-reported physician's diagnosis, fasting blood glucose, oral glucose tolerance test or glycated hemoglobin (HbA 1C ). In cross-sectional studies, compared to individuals in the highest PRL groups (reference), those in the lowest PRL groups had greater risk of type 2 diabetes both in men: odds ratio (OR) and 95% confidence interval = 1.86 (1.56–2.22) and in women: OR = 2.15 (1.63–2.85). In cohort studies, women showed a significant association between low PRL and type 2 diabetes: OR = 1.52 (1.02–2.28) but not men: OR = 1.44 (0.46–4.57). Relatively low heterogeneity was observed ( I 2 = 25–38.4%) for cross-sectional studies, but higher for cohort studies ( I 2 = 52.8–79.7%). In conclusion, low PRL is associated with type 2 diabetes, but discrepancy between men and women in the relationship within cohort studies requires further research.

Plasma Prolactin Level And Risk Of Incident Hypertension In Postmenopausal Women

Plasma Insulin-Like Growth Factor-1 Level And Risk Of Incident Hypertension In Nondiabetic Women

Plasma Resistin Levels Associate with Risk for Hypertension among Nondiabetic Women

Plasma lactate and incident hypertension in the atherosclerosis risk in communities study

Prolactin level changes according to atypical antipsychotics use: a study based on Clinical Data Warehouse

Association of High Prolactin Level on Postoperative Day 1 and Tumor Invasion with Female Gonadal Dysfunction after Trans-Sphenoidal Surgery of Pituitary Adenomas.

Association between prolactin increasing antipsychotic use and the risk of breast cancer: a retrospective observational cohort study in a United States Medicaid population

Plasma 25-Hydroxyvitamin D3 Concentrations and Risk of New-Onset Proteinuria in Patients With Hypertension

Hyperprolactinaemia is common in Chinese premenopausal women with breast diseases

Serum Prolactin Levels and Mortality in Adults Without Prolactinoma: A Meta-Analysis

An Analysis of 166 Patients with Hyperprolactinemia

Relationship Between Pregnancy Associated Plasma Protein A and Blood Pressure in Patients with Essential Hypertension

Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up

The relationship between low prolactin and type 2 diabetes

Effect of Age, Gender, Food Intake, Obesity, and Smoking on Serum Levels of Prolactin in Healthy Adults

Current guidelines and their recommendations for prolactin monitoring in psychosis

The Association Between Prolactin Levels and Cognitive Function in Female Patients With Severe Mental Disorders

Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans

Cardiometabolic profile of young women with hypoprolactinemia

An Association of Elevated Serum Prolactin with Phthalate Exposure in Adult Men.